Ellerson Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Ellerson Group's PFE Position: Q2 2026 in Review
Ellerson Group reduced its Pfizer (PFE) stake by 0.28% in Q2 2026, selling an estimated $8.4K and leaving 116,067 shares worth $2.79M. The position accounts for 1.65% of the portfolio, ranked #23.
Ellerson Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.19M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ellerson Group held 116,067 shares of Pfizer worth $2.79M as of Q2 2026.
- Ellerson Group sold 321 Pfizer shares in Q2 2026, an estimated $8.4K.
- Pfizer made up 1.65% of Ellerson Group's portfolio in Q2 2026, its #23 holding.
- Ellerson Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
- Ellerson Group's Pfizer position peaked at $4.19M in Q4 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ellerson Group's 13F filing for Q2 2026, filed 31 Jul 2026.